Clinical practice guidelines for assessment and treatment of transsexualism. SEEN Identity and Sexual Differentiation Group (GIDSEEN)
Copyright © 2012 SEEN. Published by Elsevier Espana. All rights reserved..
Transsexual patients can only be diagnosed and treated at functional gender identity Units with provision of high quality care, development of clinical practice guidelines, and interdisciplinary working groups. The therapeutic process has three mainstays: initial psychological diagnostic evaluation and psychotherapy, endocrinological evaluation and hormone therapy, and sex reassignment surgery. Cross-sex hormone therapy is essential for the anatomical and psychological transition process in duly selected patients. Hormones help optimize real-life sex identity, improve quality of life, and limit psychiatric co-morbidities often associated to lack of treatment. Development of this clinical practice guideline addresses the need for implementing a coordinated action protocol for comprehensive health care for transgender people in the National Health System.
| Errataetall: |
CommentIn: Endocrinol Nutr. 2014 Feb;61(2):116-7. - PMID 23932267 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2012 |
|---|---|
| Erschienen: |
2012 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
|---|---|
| Enthalten in: |
Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion - 59(2012), 6 vom: 01. Juni, Seite 367-82 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Guías de práctica clínica para la valoración y tratamiento de la transexualidad. Grupo de Identidad y Diferenciación Sexual de la SEEN (GIDSEEN)*(anexo 1) |
|---|
| Beteiligte Personen: |
Moreno-Pérez, Oscar [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 07.01.2013 Date Revised 24.03.2014 published: Print-Electronic CommentIn: Endocrinol Nutr. 2014 Feb;61(2):116-7. - PMID 23932267 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.endonu.2012.02.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM217377106 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM217377106 | ||
| 003 | DE-627 | ||
| 005 | 20231224033926.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2012 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.1016/j.endonu.2012.02.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0724.xml |
| 035 | |a (DE-627)NLM217377106 | ||
| 035 | |a (NLM)22542505 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Moreno-Pérez, Oscar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical practice guidelines for assessment and treatment of transsexualism. SEEN Identity and Sexual Differentiation Group (GIDSEEN) |
| 246 | 3 | 3 | |a Guías de práctica clínica para la valoración y tratamiento de la transexualidad. Grupo de Identidad y Diferenciación Sexual de la SEEN (GIDSEEN)*(anexo 1) |
| 264 | 1 | |c 2012 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.01.2013 | ||
| 500 | |a Date Revised 24.03.2014 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Endocrinol Nutr. 2014 Feb;61(2):116-7. - PMID 23932267 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2012 SEEN. Published by Elsevier Espana. All rights reserved. | ||
| 520 | |a Transsexual patients can only be diagnosed and treated at functional gender identity Units with provision of high quality care, development of clinical practice guidelines, and interdisciplinary working groups. The therapeutic process has three mainstays: initial psychological diagnostic evaluation and psychotherapy, endocrinological evaluation and hormone therapy, and sex reassignment surgery. Cross-sex hormone therapy is essential for the anatomical and psychological transition process in duly selected patients. Hormones help optimize real-life sex identity, improve quality of life, and limit psychiatric co-morbidities often associated to lack of treatment. Development of this clinical practice guideline addresses the need for implementing a coordinated action protocol for comprehensive health care for transgender people in the National Health System | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Practice Guideline | |
| 700 | 1 | |a Esteva De Antonio, Isabel |e verfasserin |4 aut | |
| 700 | 0 | |a Grupo de Identidad y Diferenciación Sexual de la SEEN (GIDSEEN) |e verfasserin |4 aut | |
| 700 | 1 | |a Albero, Ramón |e investigator |4 oth | |
| 700 | 1 | |a Almaraz, María Cruz |e investigator |4 oth | |
| 700 | 1 | |a Álvarez-Diz, José Antonio |e investigator |4 oth | |
| 700 | 1 | |a Audí, Laura |e investigator |4 oth | |
| 700 | 1 | |a Becerra, Antonio |e investigator |4 oth | |
| 700 | 1 | |a Castaño, Luis |e investigator |4 oth | |
| 700 | 1 | |a Esteva, Isabel |e investigator |4 oth | |
| 700 | 1 | |a Fernández Sánchez-Barbudo, Miguel |e investigator |4 oth | |
| 700 | 1 | |a Gómez-Balaguer, Marcelino |e investigator |4 oth | |
| 700 | 1 | |a Gómez-Gil, Esther |e investigator |4 oth | |
| 700 | 1 | |a Hurtado, Felipe |e investigator |4 oth | |
| 700 | 1 | |a López-Siguero, Juan Pedro |e investigator |4 oth | |
| 700 | 1 | |a Martínez-Tudela, Juana |e investigator |4 oth | |
| 700 | 1 | |a Moreno-Pérez, Óscar |e investigator |4 oth | |
| 700 | 1 | |a Sanisidro, Carmen |e investigator |4 oth | |
| 700 | 1 | |a Toni, Marta |e investigator |4 oth | |
| 700 | 1 | |a Vázquez-San Miguel, Federico |e investigator |4 oth | |
| 700 | 1 | |a Vidales, Angelines |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion |d 2008 |g 59(2012), 6 vom: 01. Juni, Seite 367-82 |w (DE-627)NLM190192887 |x 1579-2021 |7 nnns |
| 773 | 1 | 8 | |g volume:59 |g year:2012 |g number:6 |g day:01 |g month:06 |g pages:367-82 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.endonu.2012.02.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 59 |j 2012 |e 6 |b 01 |c 06 |h 367-82 | ||